ArticleChemical science2026
Photochemical reduction of aryl chlorides, bromides, and iodides
Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photoredox catalysis has traditionally required sophisticated catalyst design, multi-photon systems, or photoelectrochemical strategies to reach the reducing potentials necessary for aryl chloride activation. In a surprising departure from these paradigms, we find that a simple, bench-stable guanidine base, TBD, functions as a powerful photoreductant under visible light, promoting the reduction of aryl iodides, bromides, and even unactivated aryl chlorides-as well as Birch-type dearomatization of polyarenes. Mechanistic interrogation reveals an unusual ternary EDA complex formed between a TBD dimer and the aryl halide, which upon excitation engages in an electron transfer, generating aryl radicals. These intermediates enable hydrodehalogenation, borylation, and radical cyclization pathways, demonstrating broad downstream reactivity. This discovery establishes guanidine bases as a new class of photoactive reductants and highlights aggregation-driven EDA activation as a powerful and underexplored strategy for highly reducing photochemical processes.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.